Response to platelet‐activating factor in human platelets stored and aged in plasma. Decrease in aggregation, phosphoinositide turnover, and receptor affinity
- 8 July 1989
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 29 (6) , 528-533
- https://doi.org/10.1046/j.1537-2995.1989.29689318453.x
Abstract
Human platelet concentrates were stored in polyolefin bags at 22 to 24.degree. C on a horizontal shaker for up to 8 days. At different intervals, aliquots of platelet-rich plasma (PRP) were removed aseptically and five variables, i.e., platelet counts, morphology, platelet-activating factor (PAF)-simulated aggregation, phosphoinositide turnover, and [3H]PAF binding to platelet receptors, were studied. The number of platelets did not change during the 8 days of storage. Scanning electron microscopy of the platelets revealed a gradual morphologic change from biconcave flat discs to irregular, crenated forms. The PAF-induced aggregation of platelets declined with time of storage. A decrease to 50 percent of the Day 1 aggregatory response to PAF was evident on Day 2, and there was a further decline to about 20 percent by Day 6. Similarly, PAF receptor-coupled phosphoinositide turnover, as monitored by 32P incorporation into individual phosphoinositides, decreased dramatically with storage. After 2 to 3 days of storage, the phosphoinositide turnover was reduced to 50 percent of the original response, and it continued to decline to about 25 percent of original response by Day 5 or 6. The binding of [3H]PAF to washed human platelets indicated subtle changes between Days 2 and 4, which became more noticeable by Day 6. These results have raised the possibility of changes in the number of the receptors and/or their affinity for the storage for 8 days, a general deterioration of their responses to PAF occurred at the levels of cell surface receptor, transmembrane signaling (phosphoinositide turnover), and response (aggregation).Keywords
This publication has 35 references indexed in Scilit:
- Storage of platelets for tests of platelet function: effects of temperature on platelet aggregation, platelet morphology and liberation of β-thromboglobulin.Thrombosis Research, 1986
- Platelet activating factor-stimulated formation of inositol triphosphate in platelets and its regulation by various agents including Ca2+, indomethacin, CV-3988, and forskolinArchives of Biochemistry and Biophysics, 1985
- Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the plateletBiochemical Pharmacology, 1985
- Specific binding sites for platelet activating factor in human lung tissuesBiochemical and Biophysical Research Communications, 1985
- Characteristics of the binding of platelet-activating factor to platelets of different animal speciesEuropean Journal of Pharmacology, 1984
- Platelet‐activating factor is a weak platelet agonist: Evidence from normal human platelets and platelets with congenital secretion defectsAmerican Journal of Hematology, 1984
- Aberrant morphology of platelets stored in five day containersThrombosis Research, 1984
- AGEPC (platelet activating factor) induced stimulation of rabbit platelets: Effects on phosphatidylinositol, DI- and TRI-phosphoinositides and phosphatidic acid metabolismBiochemical and Biophysical Research Communications, 1982
- The loss of sialic acid and its prevention in stored human plateletsThrombosis Research, 1982
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973